Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacyHsien Hong Lin, Pei‐Jer Chen, Chao‐Wei Hsu et al.|JGH Open|2021Cited by 22
Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and ThailandSiwaporn Chainuvati, Xin Xin Zhang, Jun Cheng et al.|Hepatology International|2009Cited by 9